
Isomorphic Laboratories applies advanced AI to accelerate and improve drug discovery, enabling researchers to design molecules and predict their performance earlier in development. The company builds…

Isomorphic Laboratories applies advanced AI to accelerate and improve drug discovery, enabling researchers to design molecules and predict their performance earlier in development. The company builds…
Core proposition: AI-first drug discovery platform building on AlphaFold to design and simulate therapeutic candidates
Founded: 2021
Headquarters: King's Cross, London
Notable founder/CEO: Sir Demis Hassabis
Recent funding: $600M external round (Mar 31, 2025) led by Thrive Capital
Drug discovery and early-stage therapeutic design
2021
Biotechnology Research
$600,000,000
First external funding round; participation from GV and follow-on capital from Alphabet
“Led by Thrive Capital with participation from GV and follow-on capital from Alphabet”
| Company |
|---|
It’s hugely important for us to share knowledge and build strong relationships with each other, and we find it easier to do this if we spend time together in person.
This is why we follow a hybrid model, and would require you to be able to come into the office 3 days a week (currently Tuesday, Wednesday, and one other day depending on which team you’re in).
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week